Source: Talent4Boards

Cardurion: Cardurion Pharmaceuticals announces Amy Schulman to its Board along with a private investment from Polaris Partners

Talent4Boards - Great Talent builds Great Boards- USA, MA - Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced that it has consummated a private investment from Polaris Partners, a leading healthcare investment firm with a long history of partnering with entrepreneurs in biotechnology.... => Read full post Cardurion Pharmaceuticals announces Amy Schulman to its Board along with a private investment from Polaris Partners

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
Peter S. Lawrence's photo - President & CEO of Cardurion

President & CEO

Peter S. Lawrence

CEO Approval Rating

88/100

Read more